Golden Drugs Private Limited

Founded in 2012 and headquartered in Karnataka, India.

2012 | Bangalore, Karnataka (India) | Active
Last Updated:

Golden Drugs Profile

Key Indicators

  • Authorised Capital ₹ 4.50 Cr
  • Paid Up Capital ₹ 3.59 Cr
  • Company Age 12 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.00 Cr
  • Satisfied Charges ₹ 24.50 Cr
  • Revenue Growth -21.62%
  • Profit Growth 8.67%
  • Ebitda 49.99%
  • Net Worth -38.54%
  • Total Assets -5.28%

About Golden Drugs

Golden Drugs Private Limited (GDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 August 2012 and has a history of 12 years and eight months. Its registered office is in Bangalore, Karnataka.

The Corporate was formerly known as Golden Drug Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 3.59 Cr.

The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹24.50 Cr, as per Ministry of Corporate Affairs (MCA) records.

Shailesh Siroya and Ravindrakumar Kothari serve as directors at the Company.

Company Details

  • Location Bangalore, Karnataka
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232KA2012PTC157474

  • Company No.

    039907

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Aug 2012

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma
Company report

Golden Drugs Private Limited

Explore comprehensive data for Golden Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Golden Drugs?

Board Members (2)

NameDesignationAppointment DateStatus
Shailesh Siroya Country flag representing In Director 12-Apr-2018Current
Ravindrakumar Kothari Country flag representing In Director 15-Nov-2018Current

Financial Performance of Golden Drugs.

Golden Drugs Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 21.62% decrease. The company also saw a slight improvement in profitability, with a 8.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.54%.

Golden Drugs revenue growth over time
Golden Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-21.62%
Revenue from Operations
-21.66%
Total Assets
-5.28%
Profit or Loss
8.67%
Net Worth
-38.54%
EBITDA
49.99%

What is the Ownership and Shareholding Structure of Golden Drugs?

In 2024, Golden Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹20.00 Cr

Satisfied Charges

₹24.50 Cr

Charges Breakdown by Lending Institutions

  • Others : 20.00 Cr

Latest Charge Details

DateLenderAmountStatus
08 Feb 2024Others₹20.00 CrOpen
28 Sep 2018Tata Capital Financial Services Limited₹15.00 CrSatisfied
15 Oct 2014Punjab National Bank₹5.50 CrSatisfied
15 Oct 2014Punjab National Bank₹4.00 CrSatisfied

How Many Employees Work at Golden Drugs?

Golden Drugs has a workforce of 80 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Golden Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Golden Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Golden Drugs

Recent activity within the organization

  • Annual General Meeting

    Golden Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Golden Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

  • Charges

    A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100873015 was registered on 08 Feb 2024.

  • Charges

    A charge registered on 28 Sep 2018 via Charge ID 100207862 with Tata Capital Financial Services Limited was fully satisfied on 24 Jan 2024.

  • Director Appointment

    Ravindrakumar Kothari was appointed as a Director was appointed as a Director on 15 Nov 2018 & has been associated with this company since 6 years 5 months .

  • Charges

    A charge with Tata Capital Financial Services Limited of Rs. 15.00 Cr registered on 28 Sep 2018 with Charge ID 100207862 was modified on 17 Oct 2018.

Frequently asked questions

  • What is the Incorporation or founding date of Golden Drugs Private Limited?

    Golden Drugs Private Limited was incorporated on 27 Aug 2012.

  • What is authorized share capital and paid-up capital of Golden Drugs Private Limited?

    The authorized share capital of Golden Drugs Private Limited is ₹ 4.50 Cr and paid-up capital is ₹ 3.59 Cr.

  • Who are the current board members & directors of Golden Drugs Private Limited?

    Currently 2 directors are associated with Golden Drugs Private Limited.

    • Shailesh Dheerajmal Siroya
    • Ravindrakumar Kothari

  • What is the registered address of Golden Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Golden Drugs Private Limited is 10/1 Laxmi Narayan Complex 5Th Floor Palace Road, India, Bangalore, Karnataka, 560052.

  • What is the corporate identification number (CIN) and company number of Golden Drugs Private Limited?

    The corporate identification number (CIN) of Golden Drugs Private Limited is U24232KA2012PTC157474 and the company number is 039907 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Golden Drugs Private Limited?

    The Official website of Golden Drugs Private Limited is https://www.balpharma.com

  • What has been the recent revenue trend for Golden Drugs Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Golden Drugs Private Limited has fallen by -21.62%.

  • How many employees does Golden Drugs Private Limited currently have?

    As Per 2024 financial reports, 80 employees are currently employed by Golden Drugs Private Limited.

  • What change has been observed in the net worth of Golden Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Golden Drugs Private Limited has experienced an downturn of -38.54%.

  • What are the total open charges for Golden Drugs Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Golden Drugs Private Limited amount to ₹ 20.00 Cr.

  • When was the last Balance Sheet of Golden Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Golden Drugs Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers